{
  "trial_id": "NCT02371746",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, baseline intraocular pressure (IOP), duration of ocular hypertension or glaucoma, prior use of topical prostaglandin analogs (PGA), medical history, concomitant medications, visual acuity, central corneal thickness, cup-to-disc ratio.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Intraocular Pressure (mm Hg)",
          "baseline intraocular pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of ocular hypertension or glaucoma",
        "prior use of topical prostaglandin analogs (PGA)",
        "medical history",
        "concomitant medications",
        "visual acuity",
        "central corneal thickness",
        "cup-to-disc ratio."
      ]
    },
    "processed-gen-response": "Age, gender, race, baseline intraocular pressure (IOP), duration of ocular hypertension or glaucoma, prior use of topical prostaglandin analogs (PGA), medical history, concomitant medications, visual acuity, central corneal thickness, cup-to-disc ratio."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Intraocular Pressure (IOP), Duration of Glaucoma or Ocular Hypertension, Prior Glaucoma Medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Intraocular Pressure (mm Hg)",
          "Baseline Intraocular Pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Duration of Glaucoma or Ocular Hypertension",
        "Prior Glaucoma Medications"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline Intraocular Pressure (IOP), Duration of Glaucoma or Ocular Hypertension, Prior Glaucoma Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Diagnosis (Ocular Hypertension or Open Angle Glaucoma), Current topical PGA treatment, IOP at baseline, History of eye surgery, History of glaucoma related surgery.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Intraocular Pressure (mm Hg)",
          "IOP at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Diagnosis (Ocular Hypertension or Open Angle Glaucoma)",
        "Current topical PGA treatment",
        "History of eye surgery",
        "History of glaucoma related surgery."
      ]
    },
    "processed-gen-response": "Age, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Diagnosis (Ocular Hypertension or Open Angle Glaucoma), Current topical PGA treatment, IOP at baseline, History of eye surgery, History of glaucoma related surgery."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), medical history (including diabetes, hypertension, and cardiovascular disease), smoking status, duration of ocular hypertension or open-angle glaucoma diagnosis, current medications (including topical PGA), baseline intraocular pressure (IOP), best-corrected visual acuity, cup-to-disc ratio, central corneal thickness, and prior eye surgeries or procedures.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Intraocular Pressure (mm Hg)",
          "baseline intraocular pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "medical history (including diabetes, hypertension, and cardiovascular disease)",
        "smoking status",
        "duration of ocular hypertension or open-angle glaucoma diagnosis",
        "current medications (including topical PGA)",
        "best-corrected visual acuity",
        "cup-to-disc ratio",
        "central corneal thickness",
        "prior eye surgeries or procedures"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), medical history (including diabetes, hypertension, and cardiovascular disease), smoking status, duration of ocular hypertension or open-angle glaucoma diagnosis, current medications (including topical PGA), baseline intraocular pressure (IOP), best-corrected visual acuity, cup-to-disc ratio, central corneal thickness, and prior eye surgeries or procedures."
  }
}